Serum Phosphate Kinetics in Acute Kidney Injury After Cardiac Surgery: An Observational Study.


Journal

Journal of cardiothoracic and vascular anesthesia
ISSN: 1532-8422
Titre abrégé: J Cardiothorac Vasc Anesth
Pays: United States
ID NLM: 9110208

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 26 01 2020
revised: 11 05 2020
accepted: 18 05 2020
pubmed: 15 7 2020
medline: 28 4 2021
entrez: 15 7 2020
Statut: ppublish

Résumé

Acute kidney injury (AKI) is a common complication after cardiac surgery and may affect prognosis. Serum phosphate (SPh) elevation is well-known to occur after AKI but not well-documented. The aim of the present study was to describe SPh changes during AKI after cardiac surgery and to assess the accuracy for the diagnosis of AKI severity and recovery. Prospective, single center, observational study. Intensive care unit of a tertiary university hospital. All patients admitted consecutively to the intensive care unit between February 2015 and March 2016. AKI was defined according to Kidney Disease Improving Global Outcomes criteria and classified as nonsevere (stage 1) and severe (stages 2 and 3). Receiver operating characteristic curve analysis was conducted to test reliability of SPh for AKI severity and recovery. AKI occurred in 86 of the 260 patients included (33%) in the study; 58 (67%) experienced nonsevere AKI, and 28 (33%) experienced severe AKI. A significant elevation of SPh values was observed in AKI patients, which peaked at 48 hours. At this time, an SPh of 1.33 mmol/L demonstrated a good accuracy for AKI severity, with an area under the curve of 0.91 (95% confidence interval 0.82-1.00). For kidney recovery, a 25% SPh decrease 24 hours after the peak had a positive predictive value of 100%, and a 2.5% decrease allowed for the reclassification of patients when the serum creatinine had not decreased enough. The results showed that SPh changes closely follow AKI severity and kidney recovery after cardiac surgery. In addition to serum creatinine, this simple biological marker may help predict early favorable outcome.

Identifiants

pubmed: 32660927
pii: S1053-0770(20)30484-5
doi: 10.1053/j.jvca.2020.05.023
pii:
doi:

Substances chimiques

Biomarkers 0
Phosphates 0
Creatinine AYI8EX34EU

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2964-2972

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Marine Saour (M)

Department of Anesthesiology and Critical Care Medicine, Arnaud de Villeneuve Hospital, CHU Montpellier, Montpellier, France. Electronic address: m-saour@chu-montpellier.fr.

Norddine Zeroual (N)

Department of Anesthesiology and Critical Care Medicine, Arnaud de Villeneuve Hospital, CHU Montpellier, Montpellier, France.

Jérôme Ridolfo (J)

Department of Anesthesiology and Critical Care Medicine, Arnaud de Villeneuve Hospital, CHU Montpellier, Montpellier, France.

Erika Nogue (E)

Clinical Research and Epidemiology Unit, CHU Montpellier, Montpellier, France.

Marie-Christine Picot (MC)

Clinical Research and Epidemiology Unit, CHU Montpellier, Montpellier, France.

Philippe Gaudard (P)

Department of Anesthesiology and Critical Care Medicine, Arnaud de Villeneuve Hospital, CHU Montpellier, Montpellier, France; Montpellier University, CNRS, INSERM, PhyMedExp, Montpellier, France.

Pascal H Colson (PH)

Department of Anesthesiology and Critical Care Medicine, Arnaud de Villeneuve Hospital, CHU Montpellier, Montpellier, France; Montpellier University, CNRS, INSERM, Institut de Génomique Fonctionnelle, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH